Praxis Precision Medicines, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Praxis Precision Medicines, Inc. (PRAX) is 7.19B

According to Praxis Precision Medicines, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.19B. This represents a change of 13.43% compared to the average of 6.34B of the last 4 quarters.

Praxis Precision Medicines, Inc. (PRAX) Historical Enterprise Value (quarterly & annually)

How has PRAX Enterprise Value performed in the past?

The mean historical Enterprise Value of Praxis Precision Medicines, Inc. over the last ten years is 1.06B. The current 7.19B Enterprise Value has changed 578.30% with respect to the historical average. Over the past ten years (40 quarters), PRAX's Enterprise Value was at its highest in in the June 2026 quarter at 9.28B. The Enterprise Value was at its lowest in in the June 2023 quarter at -41088177.75.

Praxis Precision Medicines, Inc. (PRAX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Praxis Precision Medicines, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Praxis Precision Medicines, Inc. (PRAX) Average Enterprise Value

How has PRAX Enterprise Value performed in the past?

The current Enterprise Value of Praxis Precision Medicines, Inc. (PRAX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Praxis Precision Medicines, Inc. (PRAX) Enterprise Value vs. Peers

How is PRAX’s Enterprise Value compared to its peers?

Praxis Precision Medicines, Inc.’s Enterprise Value is greater than Xenon Pharmaceuticals Inc. (3.52B), greater than Supernus Pharmaceuticals, Inc. (2.30B), greater than Acadia Pharmaceuticals Inc. (3.19B), greater than Rapport Therapeutics, Inc. Common Stock (1.11B), greater than Denali Therapeutics Inc. (2.77B), greater than Axsome Therapeutics, Inc. (6.52B), less than Neurocrine Biosciences, Inc. (14.76B), greater than Neumora Therapeutics, Inc. Common Stock (-34984759.00), greater than Addex Therapeutics Ltd (2.04M), greater than Anavex Life Sciences Corp. (-9407211.00),

Build a custom stock screener for Praxis Precision Medicines, Inc. (PRAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Praxis Precision Medicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Praxis Precision Medicines, Inc. (PRAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Praxis Precision Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.